Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4

Kidney International

Volumn 80, Issue 5, 2011, Pages 504-515

  Chen, Jianlin ^a   Hartono, John R ^a   John, Reji ^a   Bennett, Michael ^a   Zhou, Xin Jin ^a   Wang, Yanxia ^a   Wu, Qingqing ^a   Winterberg, Pamela D ^a   Nagami, Glenn T ^b   Lu, Christopher Y ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Inflammation; Ischemia reperfusion; Ischemic renal failure

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC ACUTE KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RADIATION CHIMERA; ANIMAL; BIOSYNTHESIS; BONE MARROW; IMMUNOLOGY; ISCHEMIA; KIDNEY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; BONE MARROW; CHEMOTAXIS, LEUKOCYTE; HMGB1 PROTEIN; INTERLEUKIN-6; ISCHEMIA; KIDNEY; LEUKOCYTES; MALE; MICE; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 4;

EID: 84862991350     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.140     Document Type: Article

References (86)

1. Hoshino K, Takeuchi O, Kawai T et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752. (Pubitemid 29314747)
2. Wu H, Chen G, Wyburn KR et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859. (Pubitemid 47529615)
3. Pulskens WP, Teske GJ, Butter LM et al. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 2008; 3: e3596.
4. Rusai K, Sollinger D, Baumann M et al. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 2010; 25: 853-860.
5. Kruger B, Krick S, Dhillon N et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
6. Beutler B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 2009; 227: 248-263.
7. Gonzalez-Navajas JM, Fine S, Law J et al. TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J Clin Invest 2010; 120: 570-581.
8. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 2003; 112: 1234-1243. (Pubitemid 38056300)
9. Sawaki J, Tsutsui H, Hayashi N et al. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Int Immunol 2007; 19: 311-320. (Pubitemid 46344696)
10. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002; 62: 1539-1549. (Pubitemid 35286261)
11. Nemoto T, Burne MJ, Daniels F et al. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 2001; 60: 2205-2214. (Pubitemid 33070463)
12. Kelly KJ, Williams Jr WW, Colvin RB et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063. (Pubitemid 26070586)
13. De Greef KE, Ysebaert DK, Persy V et al. ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF. Kidney Int 2003; 63: 1697-1707. (Pubitemid 36513315)
14. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491. (Pubitemid 38981983)
15. Li L, Huang L, Sung SS et al. NKT cell activation mediates neutrophil IFN-{gamma} production and renal ischemia-reperfusion injury. J Immunol 2007; 178: 5899-5911. (Pubitemid 46674387)
16. Oppenheim JJ, Tewary P, de la Rosa G et al. Alarmins initiate host defense. Adv Exp Med Biol 2007; 601: 185-194.
17. Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol 2008; 3: 99-126. (Pubitemid 351488277)
18. Barton GM. A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008; 118: 413-420. (Pubitemid 351206528)
19. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469-478. (Pubitemid 38745558)
20. Lu CY, Hartono J, Senitko M et al. The inflammatory response to ischemic acute kidney injury: a result of the 'right stuff' in the 'wrong place'? Curr Opin Nephrol Hypertens 2007; 16: 83-89.
21. Patel NS, Chatterjee PK, Di Paola R et al. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 2005; 312: 1170-1178. (Pubitemid 40293778)
22. Kielar ML, John R, Bennett M et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005; 16: 3315-3325. (Pubitemid 46179335)
23. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2: 165-174. (Pubitemid 33674015)
24. Rivera J, Tessarollo L. Genetic background and the dilemma of translating mouse studies to humans. Immunity 2008; 28: 1-4.
25. Eisener-Dorman AF, Lawrence DA, Bolivar VJ. Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun 2009; 23: 318-324.
26. Burne MJ, Haq M, Matsuse H et al. Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model. Transplantation 2000; 69: 1023-1025. (Pubitemid 30174144)
27. Savransky V, Molls RR, Burne-Taney M et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int 2006; 69: 233-238. (Pubitemid 43323072)
28. Faubel S, Ljubanovic D, Reznikov L et al. Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int 2004; 66: 2202-2213. (Pubitemid 41115283)
29. Melnikov VY, Faubel S, Ljubanovic D et al. Interleukin 18 mediated ischemic acute renal failure (ARF) in mice is neutrophil-independent. J Am Soc Nephrol 2002; 13: SA-FC152.
30. Li L, Huang L, Vergis AL et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemiareperfusion injury. J Clin Invest 2010; 120: 331-342.
31. Donnahoo KK, Shames BD, Harken AH et al. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203. (Pubitemid 29420927)
32. Beck JA, Lloyd S, Hafezparast M et al. Genealogies of mouse inbred strains. Nat Genet 2000; 24: 23-25. (Pubitemid 30041415)
33. Wade CM, Kulbokas III EJ, Kirby AW et al. The mosaic structure of variation in the laboratory mouse genome. Nature 2002; 420: 574-578. (Pubitemid 35477050)
34. Mekada K, Abe K, Murakami A et al. Genetic differences among C57BL/6 substrains. Exp Anim 2009; 58: 141-149.
35. Lewis SR, Dym C, Ginzberg M et al. Genetic variance contributes to ingestive processes: a survey of mercaptoacetate-induced feeding in eleven inbred and one outbred mouse strains. Physiol Behav 2006; 88: 516-522. (Pubitemid 44093623)
36. Rhee SH, Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 2000; 275: 34035-34040.
37. Mukherjee S, Chen LY, Papadimos TJ et al. Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM. J Biol Chem 2009; 284: 29391-29398.
38. Medvedev AE, Piao W, Shoenfelt J et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 2007; 282: 16042-16053. (Pubitemid 47100380)
39. Manthey CL, Perera PY, Henricson BE et al. Endotoxin-induced early gene expression in C3H/HeJ (Lpsd) macrophages. J Immunol 1994; 153: 2653-2663.
40. Zughaier SM, Zimmer SM, Datta A et al. Differential induction of the tolllike receptor 4-MyD88-dependent and-independent signaling pathways by endotoxins. Infect Immun 2005; 73: 2940-2950. (Pubitemid 40575735)
41. Qureshi ST, Lariviere L, Leveque G et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-625. (Pubitemid 29193362)
42. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088. (Pubitemid 29001265)
43. Poltorak A, Smirnova I, Clisch R et al. Limits of a deletion spanning Tlr4 in C57BL/10ScCr mice. J Endotoxin Res 2000; 6: 51-56. (Pubitemid 30440496)
44. Poltorak A, Merlin T, Nielsen PJ et al. A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice. J Immunol 2001; 167: 2106-2111. (Pubitemid 32747519)
45. Gobe G, Willgoss DA, Hogg N et al. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 1999; 56: 1299-1304. (Pubitemid 29451235)
46. Kashgarian M. Acute tubular necrosis an ischemic renal injury. In: Jennette JC, Olsen JC, Schwartz MM, Silva FG (eds). Heptinstall's Pathology of the Kidney, 5th edn, vol.5. Philadelphia New York: Lippincott-Raven, 1999, pp 863-889.
47. Lieberthal W, Nigam SK, Bonventre JV et al. Acute renal failure. I. Relative importance of proximal vs distal tubular injury. Am J Physiol 1998; 275: F623-F631.
48. Beutler BA. TLRs and innate immunity. Blood 2009; 113: 1399-1407.
49. Mason J, Torhorst J, Welsch J. Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int 1984; 26: 283-293. (Pubitemid 14021699)
50. Yamamoto K, Wilson DR, Baumal R. Outer medullary circulatory defect in ischemic acute renal failure. Am J Pathol 1984; 116: 253-261. (Pubitemid 14053916)
51. Park KM, Kramers C, Vayssier-Taussat M et al. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002; 277: 2040-2049. (Pubitemid 34968786)
52. Chen J, John R, Richardson JA et al. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 2011; 79: 288-299.
53. De Greef KE, Ysebaert DK, Dauwe SE et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001; 60: 1415-1427. (Pubitemid 32960035)
54. Kalis C, Kanzler B, Lembo A et al. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur J Immunol 2003; 33: 798-805. (Pubitemid 36367683)
55. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210. (Pubitemid 36909930)
56. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-1164. (Pubitemid 15206810)
57. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 2000; 109: 665-678.
58. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 1999; 277: F195-F203. (Pubitemid 29415137)
59. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 2002; 282: C227-C241. (Pubitemid 34663181)
60. Arany I, Megyesi JK, Kaneto H et al. Activation of ERK or inhibition of JNK ameliorates H2O2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int 2004; 4: 1231-1239. (Pubitemid 38406961)
61. Mollica L, De Marchis F, Spitaleri A et al. Glycyrrhizin binds to highmobility group box 1 protein and inhibits its cytokine activities. Chem Biol 2007; 14: 431-441. (Pubitemid 46617319)
62. Girard JP. A direct inhibitor of HMGB1 cytokine. Chem Biol 2007; 14: 345-347.
63. Park JS, Svetkauskaite D, He Q et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377. (Pubitemid 38294612)
64. Bianchi ME. HMGB1 loves company. J Leukoc Biol 2009; 86: 573-576.
65. Hreggvidsdottir HS, Ostberg T, Wahamaa H et al. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 2009; 86: 655-662.
66. Petri B, Phillipson M, Kubes P. The physiology of leukocyte recruitment: an in vivo perspective. J Immunol 2008; 180: 6439-6446.
67. Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immunol 2007; 8: 11-13. (Pubitemid 46242350)
68. Rock KL, Latz E, Ontiveros F et al. The sterile inflammatory response. Annu Rev Immunol 2010; 28: 321-342.
69. Mollen KP, Anand RJ, Tsung A et al. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006; 26: 430-437. (Pubitemid 44632271)
70. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376: 335-376. (Pubitemid 37174535)
71. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008; 226: 10-18.
72. Shigeoka AA, Holscher TD, King AJ et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 2007; 178: 6252-6258. (Pubitemid 46717408)
73. Kuo MC, Patschan D, Patschan S et al. Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells. J Am Soc Nephrol 2008; 19: 2321-2330.
74. Yasuda H, Leelahavanichkul A, Tsunoda S et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 2008; 294: F1050-F1058.
75. Yang H, Hreggvidsdottir HS, Palmblad K et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010; 107: 11942-11947.
76. Li J, Gong Q, Zhong S et al. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant 2010; 26: 469-478.
77. Wu H, Ma J, Wang P et al. HMGB1 Contributes to Kidney Ischemia Reperfusion Injury. J Am Soc Nephrol 2010; 21: 1878-1890.
78. Wolfs TG, Buurman WA, van Schadewijk A et al. In vivo expression of Tolllike receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 2002; 168: 1286-1293. (Pubitemid 34094497)
79. Kim BS, Lim SW, Li C et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 2005; 79: 1370-1377. (Pubitemid 40740256)
80. Wang Y, John R, Chen J et al. IRF-1 promotes inflammation early after ischemic acute kidney injury. J Am Soc Nephrol 2009; 20: 1544-1555.
81. Thomas JA, Tsen MF, White DJ et al. TLR4 inactivation and rBPI(21) block burn-induced myocardial contractile dysfunction. Am J Physiol Heart Circ Physiol 2002; 283: H1645-H1655.
82. Brunt LM, Portnoy DA, Unanue ER. Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol 1990; 145: 3540-3546.
83. Kaunitz JD, Cummins VP, Mishler D et al. Inhibition of gentamicin uptake into cultured mouse proximal tubule epithelial cells by L-lysine. J Clin Pharmacol 1993; 33: 63-69. (Pubitemid 23067509)
84. Zhang Y, Woodward VK, Shelton JM et al. Ischemia/reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro. Am J Physiol Renal Physiol 2004; 286: F1193-F1201. (Pubitemid 38656376)
85. Bookout AL, Cummins CL, Mangelsdorf DJ et al. High-throughput realtime quantitative reverse transcription PCR. Curr Protoc Mol Biol 2006; Chapter 15: Unit 15.18.
86. Thurman JM, Ljubanovic D, Edelstein CL et al. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003; 170: 1517-1523. (Pubitemid 36139523)